Return To The Previous Page
Buy a Package
Number Of Visible Items Remaining : -38 Item

Potential drug interactions with NMBAs

Potential drug interactions with NMBAs
Enhance the neuromuscular effect of NMBAs Diminish the neuromuscular effect of NMBAs
  • Acetylcholinesterase inhibitors*
    • Donepezil
    • Galantamine
    • Echothiophate iodine
    • Neostigmine
    • Physostigmine
    • Pyridostigmine
    • Rivastigmine
    • Tacrine
  • Antibiotics
    • Aminoglycosides
      • Amikacin
      • Gentamicin
      • Kanamycin
      • Neomycin
      • Streptomycin
      • Tobramycin
    • Amphotericin B
    • Colistin
    • Lincosamides
      • Clindamycin
      • Lincomycin
    • Polymyxin B
  • Calcium channel blockers
    • Amlodipine
    • BepridilΔ
    • Clevidipine
    • Diltiazem
    • Felodipine
    • Isradipine
    • Nicardipine
    • Nifedipine
    • NilvadipineΔ
    • Nimodipine
    • Nisoldipine, nitrendipineΔ
    • Verapamil
  • Cyclophosphamide*
  • Loop diuretics (low doses)
    • Bumetanide
    • Ethacrynic acid
    • Furosemide
    • Torsemide
  • Magnesium Salts
  • Phenelzine*
  • Quinidine
  • Quinine
  • Trimebutine¶Δ
  • Acetylcholinesterase inhibitors
    • Donepezil
    • Galantamine
    • Neostigmine
    • Physostigmine
    • Pyridostigmine
    • Rivastigmine
    • Tacrine
  • Loop diuretics (high doses)
    • Bumetanide
    • Ethacrynic acid
    • Furosemide
    • Torsemide
Drug interactions may be different for succinylcholine (a depolarizing NMBA) versus nondepolarizing NMBAs, as designated in the footnotes. For further information refer to the specific drug information topic or the drug interactions program (available to online readers from the main search page).

NMBA: neuromuscular blocking agents.

* Succinylcholine only.

¶ Nondepolarizing NBMAs only.

Δ Not available in United States.
Graphic 68504 Version 4.0